with iPSC and phenotypic assays
Phenotypic assays with iPSC-derived cells help deciphering the full range of molecular mechanisms affected by a pathology.
Efficacy and toxicity assays become relevant to human diseases.
250 lead compounds screened from a million compounds enter pre-clinical testing
10 of them will proceed to clinical trial
1 will be approved by regulatory authorities
- For one-third, pre-clinical investigations are performed in vitro.
- Increasing the relevance of in vitro tools to the pathophysiological situation greatly improves drug screening efficacy and limits the occurrence of false-positive molecules
- Our assays are designed to monitor crucial physiological functions, including: cell death, cell proliferation. DNA repair, axonal elongation and branching (Neural stem cells), and many more...
Shift from target-based to phenotypic assays with PhenoTest
A highly qualified team of researchers and engineers is here to help accelerating your R&D programs
A dedicated and experienced team
to move your projects forward
Trusted iPSC expert
Partnering Research Organization
100% of our clients recommend Phenocell*
Your trusted partner for personnalized iPSC-based R&D solutions
*Satisfaction survey performed on Dec 2019, on a representative sample of customers
Move your R&D forward
with our innovative, efficient and cost-effective bioassays and cell models
Get in touch